InterMune (Brisbane, CA) received f...
InterMune (Brisbane, CA) received fast-track designation for Actimmune (interferon gamma-1b) injection for the treatment of idiopathic pulmonary fibrosis. The disease, which affects 50000 population in the United States, is
|